Oncogene, Published online: 25 March 2026; doi:10.1038/s41388-026-03736-6
Loss of ABCA3 disrupts lipid balance and leads to AMPK-dependent suppression of SREBP1 in glioblastoma stem cells
Oncogene, Published online: 24 March 2026; doi:10.1038/s41388-026-03728-6
TRIM21-mediated degradation of HILPDA overcomes anti-PD-1 immunotherapy resistance in breast cancer by limiting PD-L1 palmitoylation
Oncogene, Published online: 24 March 2026; doi:10.1038/s41388-026-03730-y
Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A
Oncogene, Published online: 23 March 2026; doi:10.1038/s41388-026-03734-8
PAK4 functions as an immune suppressor by reprogramming the phosphatidylcholine metabolism of CD8 + T cells within the glioblastoma tumor microenvironment
Oncogene, Published online: 23 March 2026; doi:10.1038/s41388-026-03723-x
Aryl hydrocarbon receptor is critical for both AR-dependent and AR-indifferent enzalutamide resistance in castration-resistant prostate cancer
Oncogene, Published online: 21 March 2026; doi:10.1038/s41388-026-03733-9
Cancer-associated fibroblasts as key regulators of lipid metabolism in the tumour microenvironment
Oncogene, Published online: 19 March 2026; doi:10.1038/s41388-026-03729-5
PRSS22 inhibits HMOX1-mediated ferroptosis and induces osteopontin cleavage to promote M2 macrophage polarization and colitis-associated carcinogenesis
Oncogene, Published online: 14 March 2026; doi:10.1038/s41388-026-03714-y
LINC-AC092535.5 regulates MICAL2 mRNA level to inhibit p53-mediated ferroptosis in nasopharyngeal carcinoma
Oncogene, Published online: 13 March 2026; doi:10.1038/s41388-026-03706-y
METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation
Oncogene, Published online: 09 March 2026; doi:10.1038/s41388-026-03717-9
Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD)
Oncogene, Published online: 07 March 2026; doi:10.1038/s41388-026-03709-9
CHD1 is a synthetic lethal vulnerability in MYC-driven breast cancer
Oncogene, Published online: 07 March 2026; doi:10.1038/s41388-026-03712-0
Arginine methylation-dependent stabilization of SUV39H1 promotes breast cancer growth
Oncogene, Published online: 06 March 2026; doi:10.1038/s41388-026-03708-w
Dexamethasone promotes neutrophil ROS-mediated tumor killing through the glucocorticoid receptor
Oncogene, Published online: 06 March 2026; doi:10.1038/s41388-026-03720-0
C-Jun-activated S100A10 promotes malignant progression via in diminishing ubiquitin-dependent degradation of vimentin in gastric cancer
Oncogene, Published online: 06 March 2026; doi:10.1038/s41388-026-03707-x
PMM2 interacts with TRIM28 to recruit E2F4 and promote KIFC3-mediated tumor glycolysis and colorectal cancer progression
Oncogene, Published online: 05 March 2026; doi:10.1038/s41388-026-03713-z
KRAS-extrachromosomal DNA drives intratumoral heterogeneity in gastric cancer
Login